122 lots of dietary supplement Smart Lipo are being recalled after it was learned that the drugs contain unlisted substances that have not been approved for marketing due to their dangerous health effects, the U.S. Food and Drug Administration reported on June 3.
The recall covers 22 bottles of 800 mg, 77 bottles of 900 mg, and 23 bottles of 950 mg, with expiration dates of 9/15/2017, 7/30/2017, and 7/30/2017 & 7/30/2018, respectively. Smart Lipo contains Sibutramine, an appetite suppressant pulled out from the U.S. market due to hypertension risk. The supplement also contains phenolphthalein, a drug banned from the market due to its carcinogenicity. Affected products were sold online nationwide at SmartLipo365.com.
SmartLipo365 encourages customers to dispose of the product. Customers are also asked to contact a healthcare provider if any adverse effects occurred in relation to the use of the recalled product.
At Habush Habush & Rottier S.C. ®, victims of defective and dangerous drugs may seek legal guidance and representation in filing a case against the drug manufacturer involved. Call our Milwaukee offices at (414) 271-0900 to learn more about taking legal action today.